New Blood Pressure Medication Soon To Be Available Through Canada Pharmacy

The FDA have recently approved a new drug which is directed for the treatment of high blood pressure, or hypertension. Amturnide with active ingredients amlodipine, aliskiren and hydrochlorothiazide is a new drug developed by drug manufacturer Novartis and has been proven to be extremely effective in the controlling of high blood pressure. Over 70million adults in America suffer from hypertension. Extensive clinical trials have shown that more than 80% of sufferers may require several medicines control blood pressure. If left untreated, high blood pressure increases the risk of stroke, heart attack and heart failure. Amturnide is not approved to treat or prevent stroke, heart attack and heart failure. The approval of the drug by the FDA came after the release of information from the study. The study produced results that confirmed that Amturnide was more efficient in lowering blood pressure than other combinations of its ingredients. Almost 2000 patients were involved in the studies by Novartis, and these were split into two groups - fairly high blood pressure and very high blood pressure. Both groups saw a significant decrease in blood pressure when taking Amturnide in comparison with other drugs only containing two of the active ingredients. Amturnide has been ruled safe for patients who are unable to control their high blood pressure with medications containing two of the ingredients, however it is recommended that other medications are tried by patients before beginning Amturnide. There are only two other drugs on the market which combine all three of the active ingredients in one medication. The three active ingredients previously mentioned belong to the drug groups direct renin inhibitors, with the calcium channel blockers and the diuretics. The direct rennin inhibitor Tekturna (aliskiren) is the only one of its drug group that has been approved across the globe. A Novartis spokesperson said that they are extremely happy with the approval of the new drug and that they believe this option will help patients who have struggled with medications that have been unsuccessful for them. They also said that the approval of Amturnide shows their ongoing commitment into drug research. The way that the drug works can be broken down. The aliskiren targets the system that regulates blood pressure in the body. It is a rennin inhibitor. Renin is an enzyme that the kidneys produce, and too much of this enzyme can cause the restriction of blood vessels which in turn causes high blood pressure. Amlodipine, the calcium channel blocker relaxes the muscles in the blood vessels. Finally, the diuretic hydrochlorothiazide improves the emission of water and sodium chloride. All of these effects at once reduce blood pressure considerably. Blood Pressure Treatments From Canadian Online Pharmacies Amturnide will very shortly be available through Canadian pharmacies, the safe way for you to buy prescription drugs online. However as mentioned, it is only recommended for patients whose blood pressure was unable to be regulated by other medications. Existing dual high blood pressure medications include Norvasc, Dynacirc, Isoptin, Mavik, Capoten, Altace, Hyzaar and Diovan along with many others, all available via online Canadian pharmacies, such as BigMountainDrugs.com, a leading licensed online pharmacy supplying Canada drugs. Beware of online Canadian pharmacy scams however, and ensure that you check the license with CIPA, and contact the Canada pharmacy directly- if they're legitimate their contact details will be listed on their website.